ID: ALA5197266

Max Phase: Preclinical

Molecular Formula: C21H21Cl2N7O

Molecular Weight: 458.35

Associated Items:

Representations

Canonical SMILES:  Nc1nc(NCCOc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1

Standard InChI:  InChI=1S/C21H21Cl2N7O/c22-15-5-3-7-17(18(15)23)31-11-10-26-21-29-19(24)28-20(30-21)25-9-8-13-12-27-16-6-2-1-4-14(13)16/h1-7,12,27H,8-11H2,(H4,24,25,26,28,29,30)

Standard InChI Key:  XEZKYOPQXMSHAV-UHFFFAOYSA-N

Associated Targets(Human)

Serotonin 1a (5-HT1a) receptor 14969 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 2a (5-HT2a) receptor 14758 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 6 (5-HT6) receptor 9749 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 7 (5-HT7) receptor 5576 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D2 receptor 23596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 458.35Molecular Weight (Monoisotopic): 457.1185AlogP: 4.39#Rotatable Bonds: 9
Polar Surface Area: 113.77Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.20CX LogP: 4.97CX LogD: 3.39
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.28Np Likeness Score: -1.06

References

1. Kułaga D, Drabczyk AK, Satała G, Latacz G, Rózga K, Plażuk D, Jaśkowska J..  (2022)  Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases.,  227  [PMID:34710746] [10.1016/j.ejmech.2021.113931]

Source